KT&G Corp
KRX:033780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (14.5), the stock would be worth ₩81 472.76 (54% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 31.4 | ₩176 200 |
0%
|
| 3-Year Average | 14.5 | ₩81 472.76 |
-54%
|
| 5-Year Average | 10.2 | ₩57 320.43 |
-67%
|
| Industry Average | 27.7 | ₩155 295.52 |
-12%
|
| Country Average | 9 | ₩50 466.81 |
-71%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
|
KT&G Corp
KRX:033780
|
18.3T KRW | 31.4 | 16.8 | |
| US |
|
Philip Morris International Inc
NYSE:PM
|
255.6B USD | 20.9 | 22.6 | |
| UK |
|
British American Tobacco PLC
LSE:BATS
|
94.5B GBP | 15.3 | 12.1 | |
| US |
|
Altria Group Inc
NYSE:MO
|
112B USD | 12.1 | 16.2 | |
| JP |
|
Japan Tobacco Inc
TSE:2914
|
10.3T JPY | 20 | 20.1 | |
| IN |
|
ITC Ltd
NSE:ITC
|
3.8T INR | 21.1 | 10.9 | |
| UK |
|
Imperial Brands PLC
LSE:IMB
|
22.4B GBP | 6.2 | 10.8 | |
| SE |
S
|
Swedish Match AB
F:SWMC
|
15.2B EUR | 25.5 | 25.4 | |
| CN |
|
Smoore International Holdings Ltd
HKEX:6969
|
59.2B HKD | 26.5 | 49.1 | |
| ID |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
84.9T IDR | 11.5 | 12.8 | |
| IN |
|
Godfrey Phillips India Ltd
NSE:GODFRYPHLP
|
328.7B INR | 32.5 | 26 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 4.2 |
| Median | 9 |
| 70th Percentile | 16.6 |
| Max | 2 215 132.4 |
Other Multiples
KT&G Corp
Glance View
KT&G Corp., an acronym for Korea Tobacco & Ginseng Corporation, is a unique entity in the global business landscape, epitomizing a fascinating blend of tradition and modernity. Born in South Korea, KT&G has transcended its origins to become a formidable player in both the tobacco and health supplement industries. Its roots stretch back to 1899 when it began as a state-run monopoly in Korea focusing on tobacco. Over the decades, it has successfully evolved, strategically privatizing its operations in 2002. Today, KT&G is a publicly traded company that has successfully diversified its portfolio by expanding into the fields of cosmetics and biotechnology, though tobacco and ginseng remain its flagship products. Its prowess lies in understanding the delicate balance between sectors that are not typically seen together: the addictive allure of tobacco and the wellness attributes of Korean ginseng. The financial engine of KT&G is primarily fueled by its tobacco division, which produces a vast array of cigarette brands that cater to varying consumer preferences across the globe. This segment is a powerhouse, with products that are distributed in over 50 countries, ensuring a steady stream of revenue. On the other hand, the ginseng business is another pillar of KT&G's economic structure, driven by the growing global demand for natural health supplements, including its renowned CheongKwanJang brand, which has become synonymous with quality and reliability in ginseng products. This dual approach enables KT&G to mitigate risks associated with each industry's specific challenges, creating a robust and diversified revenue model. It's a strategic maneuver allowing KT&G to capitalize on the burgeoning wellness trend while maintaining its dominant position in the tobacco market.